H.C. Wainwright raised the firm’s price target on Cingulate (CING) to $20 from $8 and keeps a Buy rating on the shares to reflect the recent ...
H.C. Wainwright lifted its price target on shares of Cingulate (NASDAQ: CING) to $20.00, a significant increase from the previous target of $8.00. The firm has maintained a Buy rating on the stock, ...
In the well-known thought experiment known as the prisoner's dilemma, one individual has to decide whether to stay silent or ...
Risking a stumble because you’re trying something hard is not just an excellent way to learn; it’s also a path to greater ...
A study published in Drug and Alcohol Dependence suggests that co-using alcohol and cannabis does not produce additional ...
Pivotal Research raised the price target for Meta Platforms, Inc. META from $800 to $875. Pivotal Research analyst Jeffrey ...